1061 related articles for article (PubMed ID: 32192494)
1. Noncoding RNAs in gastric cancer: implications for drug resistance.
Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
[TBL] [Abstract][Full Text] [Related]
2. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
[TBL] [Abstract][Full Text] [Related]
3. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
Chen C; Tang X; Liu Y; Zhu J; Liu J
Int J Oncol; 2019 May; 54(5):1511-1524. PubMed ID: 30896792
[TBL] [Abstract][Full Text] [Related]
4. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
[TBL] [Abstract][Full Text] [Related]
5. Noncoding RNAs in drug-resistant pancreatic cancer: A review.
Lin Z; Lu S; Xie X; Yi X; Huang H
Biomed Pharmacother; 2020 Nov; 131():110768. PubMed ID: 33152930
[TBL] [Abstract][Full Text] [Related]
6. Impact of MiRNAs and LncRNAs on Multidrug Resistance of Gastric Cancer.
Wu Y; Yang X; Xie Z; Hu H; Lei X; Niu D; Li S; Tuo L
Comb Chem High Throughput Screen; 2022; 25(13):2127-2140. PubMed ID: 35366768
[TBL] [Abstract][Full Text] [Related]
7. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of non-coding RNAs in gastric cancer.
Yang Q; Zhang RW; Sui PC; He HT; Ding L
World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNAs in gastric cancer carcinogenesis and metastasis.
Nasrollahzadeh-Khakiani M; Emadi-Baygi M; Schulz WA; Nikpour P
Brief Funct Genomics; 2017 May; 16(3):129-145. PubMed ID: 27122631
[TBL] [Abstract][Full Text] [Related]
10. Role of circular RNAs and long non‑coding RNAs in the clinical translation of gastric cancer (Review).
Cao B; Liu G; Zhang W; Shi Y; Wei B
Int J Mol Med; 2021 Jan; 47(1):77-91. PubMed ID: 33416088
[TBL] [Abstract][Full Text] [Related]
11. Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer.
Wei L; Sun J; Zhang N; Shen Y; Wang T; Li Z; Yang M
Front Cell Dev Biol; 2021; 9():764313. PubMed ID: 34881242
[TBL] [Abstract][Full Text] [Related]
12. Non-Coding RNA as Biomarkers and Their Role in the Pathogenesis of Gastric Cancer-A Narrative Review.
Bakinowska E; Kiełbowski K; Skórka P; Dach A; Olejnik-Wojciechowska J; Szwedkowicz A; Pawlik A
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791187
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNAs in anti-cancer drug resistance.
Chen QN; Wei CC; Wang ZX; Sun M
Oncotarget; 2017 Jan; 8(1):1925-1936. PubMed ID: 27713133
[TBL] [Abstract][Full Text] [Related]
14. LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine.
Fattahi S; Kosari-Monfared M; Golpour M; Emami Z; Ghasemiyan M; Nouri M; Akhavan-Niaki H
J Cell Physiol; 2020 Apr; 235(4):3189-3206. PubMed ID: 31595495
[TBL] [Abstract][Full Text] [Related]
15. Non-coding RNA in drug resistance of hepatocellular carcinoma.
Ding B; Lou W; Xu L; Fan W
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
[TBL] [Abstract][Full Text] [Related]
16. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
17. Noncoding RNAs in esophageal cancer: A glimpse into implications for therapy resistance.
Yang Z; Ma R; Li J; Zhao L
Pharmacol Res; 2023 Feb; 188():106678. PubMed ID: 36709789
[TBL] [Abstract][Full Text] [Related]
18. Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer.
Wei L; Sun J; Wang X; Huang Y; Huang L; Han L; Zheng Y; Xu Y; Zhang N; Yang M
Front Cell Dev Biol; 2023; 11():1226639. PubMed ID: 37560164
[TBL] [Abstract][Full Text] [Related]
19. Non‑coding RNAs that regulate the Wnt/β‑catenin signaling pathway in gastric cancer: Good cop, bad cop? (Review).
Shao Z; Gao D; Chen L; Ding W; Yu Q
Oncol Rep; 2020 Oct; 44(4):1314-1321. PubMed ID: 32945460
[TBL] [Abstract][Full Text] [Related]
20. LncRNAs: emerging biomarkers in gastric cancer.
Gu Y; Chen T; Li G; Yu X; Lu Y; Wang H; Teng L
Future Oncol; 2015; 11(17):2427-41. PubMed ID: 26289363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
